ImmunityBio Amends Officer Compensation, Code of Ethics
Ticker: IBRX · Form: 8-K · Filed: Feb 26, 2024 · CIK: 1326110
| Field | Detail |
|---|---|
| Company | Immunitybio, Inc. (IBRX) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $232,875, $298,500, $273,980 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, compensatory-arrangements, code-of-ethics
TL;DR
**ImmunityBio just tweaked executive pay and their ethics code, watch for governance shifts.**
AI Summary
ImmunityBio, Inc. filed an 8-K on February 26, 2024, reporting an event that occurred on February 22, 2024. The filing pertains to changes in compensatory arrangements for certain officers and amendments to the registrant's Code of Ethics. This indicates potential adjustments to executive compensation structures and corporate governance policies.
Why It Matters
Changes to executive compensation and the Code of Ethics can signal shifts in corporate governance, potentially impacting investor confidence and the company's operational integrity.
Risk Assessment
Risk Level: low — The filing indicates routine corporate governance updates without immediate negative implications.
Key Players & Entities
- ImmunityBio, Inc. (company) — Registrant
- February 22, 2024 (date) — Date of earliest event reported
- February 26, 2024 (date) — Filing date
- Delaware (company) — State of incorporation
- 001-37507 (dollar_amount) — Commission File Number
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 22, 2024.
What specific items were reported in this 8-K by ImmunityBio, Inc.?
ImmunityBio, Inc. reported on the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' and 'Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics'.
When was this 8-K filed with the SEC?
This 8-K was filed with the SEC on February 26, 2024.
What is the state of incorporation for ImmunityBio, Inc.?
ImmunityBio, Inc. is incorporated in Delaware.
What is the Commission File Number for ImmunityBio, Inc.?
The Commission File Number for ImmunityBio, Inc. is 001-37507.
Filing Stats: 1,003 words · 4 min read · ~3 pages · Grade level 12.5 · Accepted 2024-02-23 21:28:02
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share IBRX Nasdaq Global Select
- $232,875 — 2023 Bonus Dr. Patrick Soon-Shiong $232,875 Richard Adcock $298,500 David Sac
- $298,500 — on-Shiong $232,875 Richard Adcock $298,500 David Sachs $273,980 RSU and Opti
- $273,980 — chard Adcock $298,500 David Sachs $273,980 RSU and Option Awards Under the Long-
Filing Documents
- d785996d8k.htm (8-K) — 41KB
- 0001193125-24-044886.txt ( ) — 159KB
- ibrx-20240222.xsd (EX-101.SCH) — 3KB
- ibrx-20240222_lab.xml (EX-101.LAB) — 17KB
- ibrx-20240222_pre.xml (EX-101.PRE) — 11KB
- d785996d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMMUNITYBIO, INC. Date: February 23, 2024 By: /s/ Jason Liljestrom Jason Liljestrom General Counsel and Corporate Secretary -4-